We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First European Lab Automation Conference Convenes in Hamburg

By LabMedica International staff writers
Posted on 15 Aug 2011
The first European Lab Automation (ELA) conference and exhibition took place at the Congress Center Hamburg (CCH; Germany) from June 30–July 1, 2011. More...
The congress consisted of ten distinct tracks each addressing a specific application area, but with an underlying theme of automating the technique, equipment, or associated informatics.

With 1,523 attendees and 151 exhibitors and media partners, the feedback was overwhelmingly positive. The combination of ten comprehensive conference tracks and workshops provided useful and relevant scientific content across a range of applications within laboratory automation.

Of particular interest was the world biobanking summit, which included blood banking; standardization; harmonization; bioethics and regulations for global biobanking; and field cancer biobanking. The keynote speakers were Mary-Beth Fisk, vice president of the Texas Blood and Tissue Bank (San Antonio, TX, USA) and Prof. Malcolm Mason from Cardiff University (Wales, United Kingdom).

Mary-Beth Fisk reviewed methods for umbilical cord blood processing/cell isolation, defined technologies for cryoprotection, freezing, and storage of cells. She talked about cord blood-collection modes and outlined current statistical data related to transplantation and other clinical uses for cord blood in regenerative medicine.

Prof. Mason discussed the future of biobanking for cancer. He discussed the balance between accumulating large numbers of samples with good clinical annotation, in the light of encouraging the scientific community to use what is already available.

Some of the vendors who expressed their satisfaction with the conference exhibition included Venomtech (Ramsgate, United Kingdom), TAP Biosystems (Royston, United Kingdom), Thermo Fisher Scientific (Palm Springs, CA, USA), and KBiosystems (Basildon, United Kingdom).

Ken Browne, event organizer and director of Select Biosciences (Sudbury, UK) commented, “We are delighted with the success of the first ELA conference and exhibition and have received some fantastic feedback from vendors and delegates alike.” He continued, “We are aiming to fill the need for a pan-European Automation event, and establish ELA as the forum for combining scientific content with up-to-date technology. As such, we have already booked the date for the second ELA conference and hope to continue its success.” The venue in Hamburg is being booked for next year and the event is scheduled for May 30-31, 2012.

Related Links:

European Lab Automation


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Radial Immunodiffusion Assay
Radial Immunodifusion - C3 ID
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.